Close Menu

NEW YORK — The US Food and Drug Administration on Friday granted Emergency Use Authorization for SpectronRx's Hymon SARS-CoV-2 Test Kit.

According to the Indianapolis-based company, the test kit is designed to detect regions of the virus' nucleocapsid and envelope genes in upper respiratory specimens and bronchoalveolar lavage. It runs on Thermo Fisher Scientific's Applied Biosystems 7500 RT-PCR system.

Use of the test is limited to laboratories CLIA-certified to perform high-complexity tests, the FDA said.

The kit is manufactured by Suzhou, China-based HymonBio.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.